Literature DB >> 16544049

Complete hydatidiform mole and normal live birth following intracytoplasmic sperm injection.

Haruka Hamanoue1,2, Nobuko Umezu2, Mika Okuda2, Naoki Harada3,4, Takako Ohata1, Haruya Sakai1, Takeshi Mizuguchi1,4, Hiroshi Ishikawa2, Tsuneo Takahashi2, Kiyonori Miura5, Fumiki Hirahara2, Naomichi Matsumoto6,7.   

Abstract

A twin pregnancy with complete hydatidiform mole (HM) and preterm birth of a normal female infant after intracytoplasmic sperm injection (ICSI) conception was experienced. ICSI due to severe oligozoospermia was performed on three ova, and three embryos with confirmed two proneclei (2PN) were subsequently transferred to the uterus. At 7 weeks of gestation, molar pregnancy as well as a viable fetus was recognized. At 33 weeks, the pregnancy was terminated due to preterm labor. Dichorionic pregnancy consisting of a normal fetus and placenta in one chorionic membrane and complete HM in the other was recognized. Cytomolecular analysis indicated that the complete HM genome was derived from duplication of a single sperm, and a normal neonate was from biparental genomes. It should be noted that ICSI can avoid incomplete HM (mostly triploid) due to multi-sperm fertilization but might not be able to avoid complete HM (paternal diploid) although such a risk is very low. This is the second report of this condition and is accompanied by the first well-described molecular analysis.

Entities:  

Mesh:

Year:  2006        PMID: 16544049     DOI: 10.1007/s10038-006-0388-3

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  10 in total

1.  Repetitive complete hydatidiform mole can be biparental in origin and either male or female.

Authors:  R A Fisher; R Khatoon; F J Paradinas; A P Roberts; E S Newlands
Journal:  Hum Reprod       Date:  2000-03       Impact factor: 6.918

2.  Molecular analysis of a gestation consisting of a complete hydatidiform mole and normal dizygotic twin.

Authors:  E Ruiz-Casares; N Henriques-Gil; M Orera; R P Fernández-Pacheco; A Aguarón
Journal:  J Reprod Med       Date:  2001-12       Impact factor: 0.142

3.  Hydatidiform mole with coexistent fetus.

Authors:  W B Jones; N H Lauersen
Journal:  Am J Obstet Gynecol       Date:  1975-06-01       Impact factor: 8.661

4.  Intracytoplasmic sperm injection combined with preimplantation genetic diagnosis for the prevention of recurrent gestational trophoblastic disease.

Authors:  B E Reubinoff; A Lewin; M Verner; A Safran; J G Schenker; D Abeliovich
Journal:  Hum Reprod       Date:  1997-04       Impact factor: 6.918

5.  Hydatidiform mole coexistent with a twin live fetus: a national collaborative study in Japan.

Authors:  H Matsui; S Sekiya; T Hando; N Wake; Y Tomoda
Journal:  Hum Reprod       Date:  2000-03       Impact factor: 6.918

6.  Molar pregnancy with a coexistent fetus after intracytoplasmic sperm injection. A case report.

Authors:  P Petignat; A Senn; P Hohlfeld; S A Blant; R Laurini; M Germond
Journal:  J Reprod Med       Date:  2001-03       Impact factor: 0.142

7.  Androgenetic origin of hydatidiform mole.

Authors:  T Kajii; K Ohama
Journal:  Nature       Date:  1977-08-18       Impact factor: 49.962

8.  Human triploidy: relationship between parental origin of the additional haploid complement and development of partial hydatidiform mole.

Authors:  P A Jacobs; A E Szulman; J Funkhouser; J S Matsuura; C C Wilson
Journal:  Ann Hum Genet       Date:  1982-07       Impact factor: 1.670

9.  High incidence of triploidy in in-vitro fertilized oocytes from a patient with a previous history of recurrent gestational trophoblastic disease.

Authors:  L Pal; T L Toth; L Leykin; K B Isaacson
Journal:  Hum Reprod       Date:  1996-07       Impact factor: 6.918

Review 10.  Modern management of gestational trophoblastic disease.

Authors:  T W McDonald; E H Ruffolo
Journal:  Obstet Gynecol Surv       Date:  1983-02       Impact factor: 2.347

  10 in total
  1 in total

1.  Twin Pregnancy of a Complete Hydatidform Mole and a Co-existent Fetus: A Very Rare Case Report.

Authors:  Afsaneh Tabandeh; Mahsa Besharat
Journal:  Iran Red Crescent Med J       Date:  2013-08-05       Impact factor: 0.611

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.